AFAR
AFAR About Us our grantees news center support afar publications links contact us
Grants Grants & Applications Meetings eweson lectures
Fountain of Youth

Contact: Stacey Harris
212-703-9977
stacey@afar.org


AFAR Hosts Conference on Biomarkers of Aging
and Diseases of Aging

Scientists, industry leaders assessed current and futures status of biomarkers as
identifiers of rates of biological aging, predictors of longevity, and indicators of
susceptibility to age-related diseases


On October 2, 2007, more than 200 scientists and industry leaders attended Seeking Biomarkers of Aging and Diseases of Aging, a scientific conference sponsored by the American Federation for Aging Research (AFAR).

The interactive conference featured presentations highlighting the resources available for aging biomarker research and the kind of biomarkers needed to provide improvements to the human condition by alleviating disease and extending healthy lifespan. A forum with industry discussed public-private partnerships for the development of more useful biomarkers and effective interventions that could ultimately identify, treat and track age-related diseases and disorders.

Richard Hodes, MD, Director of the National Institute on Aging, presented the keynote address, "The Outlook for Biological Research on Aging." Other speakers included: Stephen L. Helfand, MD, Brown University; Donald Ingram, PhD, Pennington Biomedical Research Center/Louisiana State University; Gerald McClearn, PhD, Penn State University; Richard A. Miller, MD, PhD, University of Michigan; Richard Sprott, The Ellison Medical Foundation; and Richard Weindruch, PhD, University of Wisconsin.

All speaker presentations can be found as read-only files here. The files are very large, so please make sure to save to your computer before viewing.

A full program listing can be found at http://www.afar.org/biomarkersconference.html.

Read about the proceedings of the conference.


Donald Ingram discusses the aging genius

AFAR gratefully acknowledges the underwriters of this conference which include: Anonymous, Applied Biosystems/MDS SCIEX, AstraZeneca, The Ellison Medical Foundation, GE Healthcare, GlaxoSmithKline, The Glenn Foundation for Medical Research, Merck, Myriad Pharmaceuticals, Inc., National Institute on Aging, Nestlé SA, Ortho-McNeil Neurologics, Inc., Pfizer, sanofi-aventis, and the 2007 Dorothy Dillon Eweson Lecture Series.

###

The American Federation for Aging Research (AFAR) is a nonprofit organization whose mission is to support biomedical research on aging. It is devoted to creating the knowledge that all of us need to live healthy, productive, and independent lives. Since 1981, AFAR has awarded approximately $100 million to more than 2,400 talented scientists as part of its broad-based series of grant programs. Its work has led to significant advances in our understanding of the aging process, age-related diseases, and healthy aging practices. AFAR communicates news of these innovations through its organizational web site, www.afar.org, and educational web sites, Infoaging (www.infoaging.org) and Health Compass (www.healthcompass.org).


Back to AFAR News


American Federation for Aging Research (AFAR) | 55 West 39th Street, 16th Floor | New York, NY 10018
Phone: (212) 703-9977 | Toll-free: (888) 582-2327 | Fax: (212) 997-0330
E-mail: grants@afar.org or info@afar.org